# To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults

> **NCT07655960** · PHASE1 · COMPLETED · sponsor: **AJU Pharm Co., Ltd.** · enrollment: 41 (actual)

## Conditions studied

- Hypercholesterolemia
- Dyslipidemia

## Interventions

- **DRUG:** Test Drug
- **DRUG:** Reference Drug

## Key facts

- **NCT ID:** NCT07655960
- **Lead sponsor:** AJU Pharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-06-11
- **Primary completion:** 2026-06-19
- **Final completion:** 2026-07-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655960, "To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07655960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*